Camtek to Present at the Needham Growth Conference on January 14
Get Alerts CAMT Hot Sheet
Join SI Premium – FREE
MIGDAL HA'EMEK, Israel, Jan. 6, 2020 /PRNewswire/ -- Camtek Ltd. (NASDAQ: CAMT)(TASE: CAMT) announced that it will be presenting at the 22nd Annual Needham Growth Conference to be held between January 14-15, 2020 at the Lotte New York Palace Hotel in New York.
Camtek is scheduled to present on Tuesday, January 14, 2020 at 10:40am Eastern Time.
At the conference there will be an opportunity for investors to meet one-on-one with Rafi Amit, CEO of Camtek. Interested investors should contact the conference organizers at Needham or the Investor Relations team at Camtek.
ABOUT CAMTEK LTD.
Camtek is a leading manufacturer of metrology and inspection equipment and a provider of software solutions serving the Advanced Packaging, Memory, CMOS Image Sensors, MEMS, RF and other segments in the mid end of the semiconductor industry.
Camtek provides dedicated solutions and crucial yield-enhancement data, enabling manufacturers to improve yield and drive down their production costs.
With eight offices around the world, Camtek has best-in-class sales and customer support organization, providing tailor-made solutions in line with customers' requirements.
This press release is available at http://www.camtek.com
Contact:
CAMTEK LTD. Moshe Eisenberg, CFO Tel: +972-4-604-8308 Mobile: +972-54-900-7100 [email protected] INTERNATIONAL INVESTOR RELATIONS GK Investor Relations Ehud Helft / Gavriel Frohwein Tel: (US) +1-646-688-3559 [email protected]
View original content:http://www.prnewswire.com/news-releases/camtek-to-present-at-the-needham-growth-conference-on-january-14-300981603.html
SOURCE Camtek Ltd
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Inner Circle acknowledges Suzanne Dana as a Pinnacle Professional Member Inner Circle of Excellence
- Transformational Wellness Launches Bay Area Wellness Week to Connect Community Wellness With Global Humanitarian Action
- Aureka Biotechnologies Raises US$100 Million Series B to Build a Biological World Model for Drug Discovery
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share